David A Fidock is an expert in Infectiology at Columbia University Medical Center (United States). As of October 2026, ScienceLeadR ranks David A Fidock in the top 1% of experts worldwide for Mosquito-Borne Diseases, Drug Discovery and Drug Development. David A Fidock has authored 375 publications, the most recent in 2026. SLR score: 1,621 (community average: 125). How the SLR is computed.

LeadR Profile

David A Fidock Columbia University Medical Center United States
1 621 ScienceLeadR Reputation 1621
Network Map

Infectiology

Subspecialties: Biochemistry - Pharmacy - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1987 - 2026

Source: PubMed

Institut Pasteur

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 375

Citations

Citations: 30 748 1st author: 18 Last author: 105 Unique author: 4


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
In vitro pharmacodynamics of the antimalarial drug cabamiquine.
PMID 42714380 — luciferases, cells, growth, pharmaceutical preparations, drug therapy, parasites, therapeutics, antimalarials, anti-bacterial agents, antiviral agents
Antimicrob Agents Chemother20260
Discovery of Sphaeriaurantins as Rapid-Acting Antiplasmodials with Dual Activity in Blood and Liver Stages.
PMID 42619137 — malaria, blood, pharmaceutical preparations, liver, antimalarials
J Am Chem Soc20260
Peptidic Phosphonates as Irreversible Covalent Inhibitors of Plasmodium falciparum Serine Protease PfSUB1.
PMID 42621424 — serine proteases, pharmaceutical preparations, peptide hydrolases, parasites, antimalarials, serine
ACS Med Chem Lett20260
Genomic surveillance reveals co-occurrence of Plasmodium falciparum drug resistance variants across diverse transmission settings in Ethiopia.
PMID 42557356 — malaria, pharmaceutical preparations, chloroquine, haplotypes, lumefantrine, therapeutics, antimalarials, drug resistance
Nat Microbiol20260
Antimalarial cytoskeletal targeting with broad apicomplexan activity.
PMID 42497201 — cells, malaria, actins, laboratories, blood, myosins, sporozoites, liver, parasitic diseases, parasites, antimalarials
Proc Natl Acad Sci U S A20261

LeadR Networks

Main global connection map